G1 Therapeutics Inc (GTHX) is down 2.63% Monday In Premarket Trading

G1 Therapeutics Inc (GTHX) is lower by Monday morning, with the stock falling -2.63% in pre-market trading to 1.48. GTHX's short-term technical score of 12 indicates that the stock has traded less bullishly over the last month than 88% of stocks on the market. In the Biotechnology industry, which ranks 134 out of 146 industries, GTHX ranks higher than 24% of stocks. G1 Therapeutics Inc has risen 5.56% over the past month, closing at $1.36 on October 2. During this period of time, the stock fell as low as $1.12 and as high as $1.58. GTHX has an average analyst recommendation of Strong Buy. The company has an average price target of $11.40.

GTHX has an Overall Score of 42. Find out what this means to you and get the rest of the rankings on GTHX!

See Full GTHX Report

G1 Therapeutics Inc has a Long-Term Technical rank of 22. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 78% of the market scoring higher. In the Biotechnology industry which is number 132 by this metric, GTHX ranks better than 132% of stocks.

Important Dates for Investors in GTHX:

-G1 Therapeutics Inc is set to release earnings on 2023-11-01. Over the last 12 months, the company has reported EPS of $-1.70. -We do not have a set dividend date for G1 Therapeutics Inc at this time. Click Here To Get The Full Report on G1 Therapeutics Inc (GTHX)